Should I Invest In Standard Chartered PLC Now?

Can Standard Chartered PLC (LON: STAN) still deliver a decent investment return?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I seem utterly incapable of talking about banking shares without mentioning cyclicality. Do I need psychiatric help? Maybe, but one thing is certain, holding banking shares now is enough to give any investor the spooks.

Growing, growing, gone

Take Asia-focused Standard Chartered (LSE: STAN), for example, which oozes growth potential, and has done for a long time. Last year, the firm earned about 82% of its operating profit from Asia and 10% from Africa, two up-and-coming markets that seem likely to expand in the years ahead — what better way to play emerging markets than with a bank, we may ask.

The trouble is that Standard Chartered’s shares fell from a post-credit-crunch high around 1950p achieved during 2010 to 951p today. That’s an investing disaster for anyone holding on for the last four years, and one that apparently snatches defeat from the jaws of victory, after all, the firm’s financial record suggests trading improved over the period:

Year to December

2009

2010

2011

2012

2013

Operating profit ($m)

5,130

6,080

6,701

8,061

8,584

Net cash from operations ($m)

(4,754)

(16,635)

18,370

17,863

9,305

What on earth is going on, then?

Cyclicality — pass the pills, nurse!

Stock markets allow for cyclicality, and there’s no sector more cyclical than that of the financials. Sooner or later, thinks the market, Standard Chartered’s and other financial companies’ profit and cash flow progress will reverse as general economic conditions deteriorate again. So, improving trading doesn’t impress, and valuations reduce — as profits rise, P/E ratings tend to fall.  

The market knows that every improvement in trading moves us closer to peak profits, which precede the next cyclical plunge in earnings. The forward-looking market doesn’t want to be caught out, so it keeps valuations down. Furthermore, if there’s the slightest whiff of a decline in economic activity, which could seriously affect the profits of cyclical firms, share prices will plunge. That’s what happened over the last couple of years with Standard Chartered as news emerged of weakness in its markets.

So where are we now?

In a recent update, Standard Chartered’s chief executive said that trading conditions are subdued. The firm is reprioritising investments, exiting non-core businesses, de-risking certain portfolios and reallocating capital. There’s a focus on costs, and the company aims to save more than US$400 million in productivity improvements during 2015. The actions the firm plans will likely affect near- term performance, but they are crucial to getting Standard Chartered back on a trajectory of sustainable, profitable growth, he reckons.

Right now, Standard Chartered looks more like a firm struggling to turn its fortunes around than a company intent on world domination through growth. That’s the unfortunate truth, but we need look no further than the affects of cyclicality to identify the culprit.

The shares trade on a forward P/E rating just over eight for 2015 and City analysts predict a 10% earnings’ rebound that year. Meanwhile, there’s a 5.6% dividend yield with the payout covered more than twice by adjusted forward earnings.

The share price seems to have plunged recently, so is it time to buy now? I don’t know. The cyclicals are so hard to judge, and that’s the problem. Do we need a bank in our portfolios at all, particularly when there are firms with strong trading franchises that can really drive wealth creation if we buy the shares at sensible prices?

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold does not own shares in Standard Chartered.

More on Investing Articles

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »

Young Caucasian girl showing and pointing up with fingers number three against yellow background
Investing Articles

3 FTSE stocks I wouldn’t ‘Sell in May’

If the strategy had any merit in the past, I see no compelling evidence it's a smart idea today. Here…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

Down 21% and yielding 10%, is this income stock a top contrarian buy now?

Despite its falling share price, this Fool reckons he's found an income stock that could be worth taking a closer…

Read more »